Its also worth noting that intensive insulin therapy is the standard of care for all critically ill patients, regardless of underlying disease, with the aim of reducing hyperglycaemia associated with the acute phase of injury which facilitates inflammation and sepsis49. The gene discussed is INS; the disease is Hyperglycemia.